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Those asked for their opinions included: people with epilepsy, living with the condition every day; a healthcare provider working in the social care sector; a teacher/support worker working with learning disability service users; a staff development manager responsible for accessing high-quality staff training; and a carer of a person with epilepsy living at home in a domestic setting. So -a diverse group, each with a different perspective, but highlighting some common ground where they felt progress can and should be made.
All of these people, experts in their own field, were adamant that things needed to change; in some instances they felt progress could be achieved in the short term; but others were perceived as targeting more fundamental changes that would effectively only achieve fruition if dealt with over a broader time scale. These changes would also mean that attitudes within the health care system and the wider community would need to evolve to sustain them. How to achieve this? A complex question, I feel, for which no simple answer could be given. Here, however, is an overview of discusants' priorities.
Training
This was seen as a vital component of any plans for the future and was identified as needed by all sections of the care professions:
Medically/professionally qualified staff in different spheres, i.e. physiotherapists, occupational therapists, technicians, etc. Those people who make up the vast majority of care staff in care establishments all over the country.
In the medical sphere, specialist training and allocation of funding is required to provide more neurologists specifically trained and specialising in diagnosis and care for the identified high population in the UK who are living with and being affected by epilepsy; and to access the equipment needed.
It would be important to ensure that staffs in all areas of care are able to access funding, are trained to a high standard and have the background knowledge to effectively, appropriately and acceptably care for the different types of client who present with epilepsy. This would include the population of people with learning disability, of whom a large percentage have epilepsy as an integral factor. This would result in specific and highly specialised care, the positive effects of which cannot be underestimated.
An important suggestion made was that training for all doctors, nurses and other health professionals should include seminars given by people in a position to tell the 'expert professionals' 'the real life' unexpurgated truth about the everyday highs and lows of living with the condition. A carer's view would also be important, as this would heighten awareness of the difficulties that they may experience by being in that position. This is something that holistic care is meant to address, but for which there are variable results.
Choice
Those individuals living with the condition felt that they should:
be an equal party in consultations on their treatments; have all aspects of their treatment explained thoroughly; should where possible, be able to make independent decisions. If necessary patients advocates should be used to ensure this is done and that the individual concerned comprehends the options; this was seen as of paramount importance by my discussants.
To achieve this, relevant unbiased information on treatments should be made available, written in simple terms, and including information about risks, side effects, long-term implications and expected outcomes on the individual's life now and in the future.
Medication
It was felt important that treatments which promoted the dignity and respect of the service user in relation to administration were promoted. In the short term, this would involve drugs like buccal Midazolam or an equivalent being licensed in a timely fashion, obviating use of rectal medications. This mode of administration was seen by the group as a 'most intrusive' and a 'socially unacceptable' practice, although accepted as a 'necessary evil'. In some areas of the country it is still authorised and carried out; some hospital trusts will not sanction prescribing in deference to NICE guidelines and canvassed patient opinion. 
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Centres for treatment
With the main large centres for epilepsy being scattered as they are around the UK, patients requiring specialist treatment often have to travel extensively to access the expertise they need. While these centres offer excellent facilities, travelling great distances was deemed unacceptable and in some cases may mean that choice is eroded.
Awareness
In 2010 although things have improved there is consensus that in the UK there is still a long way to go in helping the average person appreciate what epilepsy is and how it affects individuals living with it in their community. Outdated ideas still persist and this extends to employers and the workplace, education establishments and schools and more generally in our communities. A lot of work is carried out by the voluntary specialist epilepsy sector charities and they are acknowledged as doing a fantastic job, but discussants felt that until the Government, whichever political party is in power, gets to grips with the situation, nothing significant will be achieved. It has been proven that when (as was the case for Dementia) the government embraces a programme of initiatives to highlight an individual long-term condition, public expectations are raised and treatment and funding efforts are improved.
Support
With the involvement of the UK NHS and various white papers, there are avenues available for patients to access support. For example, the Expert Patient Programme operates in most parts of the country and plays a large part in supporting those living with a range of long-term conditions, including epilepsy. Free six-week courses also encourage/allow them to meet others in the same position-living with a condition that affects every area of their life and is long-term. This can be a very positive experience, at the same time addressing current government guidelines on encouraging self-help in such patients.
Carer support is vital as their input, besides saving the country millions in care costs, also means the person with epilepsy can be with their family if they choose to and if this is acceptable to all concerned. Information and sharing of aspects of treatment and diagnosis are vital. Carers are the link that provides professionals with the information they need to diagnose and treat the patient in many situations. It should also be borne in mind that the person may wish to exercise their right to independent living and this should also be supported where possible.
If the circumstances dictate an integrated home care service which is researched and backed up by qualified well informed and skilled professionals will make the transition between care and home a good experience. A 'joined up' system of care is the way forward with any illness or condition. A real challenge for the future!
Research
Personally I feel that over the last 30 years (a period which encompasses my personal treatment and care), great inroads have been made into understanding the many aspects of epilepsy-and this is to be applauded. If one considers aspects of care such as medication, diagnosis and the classification of different types of seizures, much progress has been made.
Research made possible by interest from drug companies has meant that a wide variety of drugs have been introduced. This has been beneficial in eliminating from common use some of the medications found, retrospectively, to be responsible for unwelcome long-term effects such as eye problems and dementia. Conversely, it has brought drugs such as Keppra, (Leviracetam) Vimpat (Lacosamide) into the therapeutic arena. In the future, such pharmaceutical interventions will, I would hope, continue and be of great benefit. Further large scale surveys and trials, of the sort undertaken in Parkinson's disease, would be helpful.
Funding for scanners which can accurately identify damaged areas of the brain and in some cases allow removal has meant surgery is providing a safer, cost effective, feasible option. Results show that significant benefits are achievable, allowing an individual to recapture a relatively normal life. It is research that has made these innovations possible-and again the future looks very promising in this direction.
Genetic research and the factors which make individuals more likely to have epilepsy is ongoing and has the propensity to highlight information for future generations. I personally think this is an area that holds the prospect of the most exciting breakthrough. It was accidental that many great scientific breakthroughs were made; and if governments do not fund research, these risk being lost. Controlled studies replicating evidence found will not happen where there is a lack of resources and so potentially valuable data will be lost and valuable opportunities missed for the person praying for a resolution to their illness.
To sum up, then, the views of my discussants, I would say that what is needed for the future is:
Epilepsy care needs prioritised for each of the 456,000 individuals living with the condition in the UK. High-quality care by trained professionals with an interest and understanding of the condition. Adequate funding for research from preferably independent sources to get unbiased views on drugs, genetics and the best way forward for care.
More research into what the individual with epilepsy would like. Training for doctors, nurses and other care staff which is of a high standard and relates to current and future evidence-based practice. An integrated support system for those with epilepsy and their carers to ensure that it is in line with individual wishes.
Tall orders, maybe, but we can hope that the speed of developments seen over the next 60 years will be as monumental as those seen over the last 60-and that epilepsy care will be transformed in all these areas.
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